Hepatitis C News

In addition to preventing premature death, treatment of hepatitis C with direct-acting antiviral agents can be significantly cost-saving for many countries, researchers reported at the Liver Meeting Digital Experience.

Treatment of hepatitis C virus in high-risk people via methadone clinics showed high rates of sustained virologic response, according to a presentation at The Digital Liver Meeting Experience.

Patients who received all medication up front and only monitored via two phone calls over 12 weeks achieved 95% sustained virologic response, according to a presentation at The Digital Liver Meeting Experience.

New data indicate that circulating microRNAs may increased risk for hepatocellular carcinoma among patients with chronic hepatitis C-related cirrhosis and a sustained virologic response.

Universal screening of all adults and improved treatment rates are needed to achieve WHO goals designed to eliminate hepatitis C as a public health threat by 2030, according to a study presented during the Liver Meeting Digital Experience.

In a model presented at The Liver Meeting Digital Experience, experts showed that at-risk populations could be positively impacted by incremental changes in hepatitis C screening and treatment strategies.

In a comparison of two treatment models for HCV, researchers found that both were effective among people who injected drugs.

Using two methods of engagement – with methadone treatment or in a navigation setting – researchers at The Digital Liver Meeting Experience showed people who inject drugs can achieve viral response in hepatitis C virus.

Two epidemiological studies presented at The Digital Liver Meeting Experience revealed the work left in achieving elimination goals in hepatitis C virus.

Despite little contact with providers, patients in a minimal monitoring scenario achieved ‘cure’ of their hepatitis C virus, according to a presentation at The Digital Liver Meeting Experience.